medRxiv
August 22, 2023
Yasmin Lalani, Alexandra Godinho, Kirsten Ellison et al.
preprint
Abstract Background People with cancer experience heightened levels of stress and anxiety, including psychological or physical. In recent years, digitally delivered complimentary therapies, such as meditation, have gained attention in cancer research and advocacy communities for improving quality of life. However, most digital meditation resources are commercially available and are not tailored...
American Journal of Psychiatry and Neuroscience
August 17, 2023
Marcus C. Rosenhagen, Julien Elowe, Alberto Forte et al.
Ketamine, initially developed as a safer alternative to phencyclidine, has emerged as a groundbreaking treatment in psychiatric practice. It gained popularity after its approval by the FDA in 1970 for its analgesic properties and ability to induce altered consciousness while maintaining vital functions. In the 1990s, researchers discovered its rapid and potent antidepressant effects, especially...
Jurnal Keperawatan Mandira Cendikia
August 16, 2023
Resti Pratiwi
Semakin meningkatnya usia maka semakin banyak permasalahan kesehatan yang dirasakan oleh lansia, selain penyakit fisik lansia juga kerap mengalami permasalahan mental seperti kesepian, kecemasan dan depresi. Tingkat prevalensi kecemasan berdasarkan usia dan jenis kelamin, memuncak pada usia dewasa tua, diatas 7,5% diantaranya perempuan berusia 55-74 tahun, diatas 5,5% di antaranya laki-laki,...
Journal of Affective Disorders
August 15, 2023
Silvia J. Franco-Corso, Kate Y O'Malley, Saleena Subaiya et al.
12 citations
Research with hallucinogens suggests that non-ordinary states of consciousness (NOSCs), particularly mystical-type experiences, predict improvements in various affective disorders and substance use disorders (SUDs). Little is known, however, about the therapeutic potential of NOSCs induced by mind-body practices such as meditation, yoga and breathwork. We conducted a literature review in online...
The Journal of Clinical Psychiatry
August 14, 2023
Michael E. Thase
9 citations
Among the greatest unmet needs in major depressive disorder (MDD) is a lack of effective pharmacotherapies for patients who do not respond to first- and second-line antidepressant medications. After decades of muted progress, optimism regarding the future of MDD therapy rose after scientists serendipitously uncovered the antidepressant effects of ketamine. The discovery of ketamine's...
International Journal of Environmental Research and Public Health
August 13, 2023
Johnathan M Herczyk, Keith J Zullig, Stephen M Davis et al.
Background: Elevated mental illness prevalence complicates efforts designed to address the opioid crisis in Appalachia. The recovery community acknowledges that loneliness impacts mood and engagement in care factors; however, the predictive relationship between loneliness and retention in medication-assisted outpatient treatment programs has not been explored. Our objectives were to identify...
Biomedical Signal Processing and Control
August 12, 2023
Pedro Correia, Cláudia Quaresma, Pedro Henrique de Paula Ramalho Morais et al.
10 citations
In recent years the psychophysiological benefits of Mindfulness meditation on emotional processing have drawn great interest in scientific research. Currently, the effects of this meditation practice on stress, anxiety and well-being have been mostly evaluated using self-reporting questionnaires, which lead to a quite subjective assessment. This study assesses the effect of Mindfulness practice...
ACS Medicinal Chemistry Letters
August 10, 2023
Robert B. Kargbo
Depression is a widespread issue in the United States and the leading cause of disability globally, impacting people of all ages. Although selective serotonin reuptake inhibitors (SSRIs) are commonly used for treatment, they have limited effectiveness and may take weeks to show results. There is a pressing need for fast and effective solutions for various types of depression, including chronic,...
Journal of the American Psychiatric Nurses Association
August 10, 2023
G. Pearson
The use of psychedelic medications to treat the brain disorders associated with psychiatric illness has re-emerged in recent years as a viable treatment option (Grieco et al., 2022). Historically there is evidence of hallucinogenic use in religious and spiritual rituals dating back to 500 B.C. (Begola & Dowben, 2018). The discovery of LSD (lysergic acid diethylamine-25) in Switzerland in 1943...
Frontiers in Psychology
August 9, 2023
Patric Plesa, Rotem Petranker
The resurgence of psychedelic research explicitly targets treating mental health conditions largely through psychedelics-assisted psychotherapy. Current theories about mechanisms of change in psychedelics-assisted psychotherapy focus on mystical experiences as the main driver of symptom improvement. During these mystical experiences, participants report an enhanced sense of salience,...